Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Udit Batra named CEO, Merck KGaA's life science division

This article was originally published in Scrip

Executive Summary

EMD Millipore, the life sciences division of Merck KGaA, has named Dr Udit Batra president and chief executive officer – effective 15 May 2014. Dr Batra will lead EMD Millipore's strategic direction and operation from its US headquarters in greater Boston, Massachusetts, and will focus on the globalization and growth of the company. He joins EMD Millipore from Merck KGaA's consumer health division. Prior to his time at Merck KGaA, Dr Batra was head of global public health and market access at Novartis Vaccines and Diagnostics.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts